Jan 14 Pfizer Inc is considering buying
India's Agila Specialties, the injectable-medicines unit of
Indian drug supplier Strides Arcolab Ltd, for a
possible price of $2 billion, Bloomberg reported on Monday.
Pfizer is doing due diligence and a deal could be reached
this quarter, Bloomberg reported, citing unnamed sources.
A Pfizer spokeswoman said the company does not comment on
market rumors or speculation.
Agila makes cancer treatments and antibiotics, Bloomberg
Pfizer shares were up 23 cents at $26.75 on the New York